In addition, severe vascular calcification in patients with stage 3-4 CKD is associated with high serum bile acid levels in these patients, particularly their free DCA levels; FXR/TGR5 dual agonist (INT-767) treatment in mice reduces the levels of CA and CA-derived bile acids, such as DCA35,38. Here, NR1H4 is linked to chronic kidney disease.